Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update
Go back to Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 2.46 -0.13 (5.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.59 | 52 Week High | $3.64 | |||
| Open | $2.57 | 52 Week Low | $0.14 | |||
| Day High | $2.70 | P/E | N/A | |||
| Day Low | $2.45 | EPS | $0.00 | |||
| Volume | 638,938 | |||||

